Notably, the AFP levels in SVRs were significantly lower than those in treatment-naïve HCV patients, even those with cirrhosis, in accordance with the previous findings of Nguyen et al. [40] and, more recently, Elbadry et al., who assessed the impact of DAAs on the health-related quality of life of Egyptian SVR patients [41]. This evidence concerns the gene AFP and Cirrhosis.